Amgen (AMGN) Tops Q1 EPS by 16c
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $379.37 +0.80%
EPS Growth %: +2.7%
Financial Fact:
Total revenues: 5.81B
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +2.7%
Financial Fact:
Total revenues: 5.81B
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $3.98, $0.16 better than the analyst estimate of $3.82. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $6.12 billion.
GUIDANCE:
Amgen sees FY 2023 EPS of $17.60-$18.70, versus the consensus of $17.72. Amgen sees FY 2023 revenue of $26.2-27.3 billion, versus the consensus of $26.7 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Could Affirm be a $200 stock?
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
